ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 140 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,976,625 | +485.9% | 77,363 | +557.6% | 0.00% | – |
| Q2 2023 | $337,392 | +13510.0% | 11,764 | -88.6% | 0.00% | -100.0% |
| Q1 2023 | $2,479 | +253.1% | 103,411 | +149.9% | 0.00% | – |
| Q4 2022 | $702 | -99.7% | 41,387 | +124.2% | 0.00% | – |
| Q3 2022 | $274,000 | -91.5% | 18,461 | -91.0% | 0.00% | -100.0% |
| Q2 2022 | $3,220,000 | -24.3% | 204,596 | +129.7% | 0.00% | -33.3% |
| Q3 2021 | $4,256,000 | -69.3% | 89,075 | -73.5% | 0.00% | -70.0% |
| Q1 2021 | $13,883,000 | +936.8% | 336,138 | +989.1% | 0.01% | +900.0% |
| Q4 2020 | $1,339,000 | +357.0% | 30,865 | +391.8% | 0.00% | – |
| Q2 2020 | $293,000 | -78.5% | 6,276 | -93.7% | 0.00% | -100.0% |
| Q1 2020 | $1,363,000 | – | 100,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DFPG INVESTMENTS, LLC | 456,390 | $5,541,000 | 3.62% |
| DAFNA Capital Management LLC | 173,914 | $1,890,000 | 0.65% |
| One68 Global Capital, LLC | 19,861 | $216,000 | 0.47% |
| Diametric Capital, LP | 51,982 | $565,000 | 0.41% |
| ARK Investment Management | 1,383,756 | $15,041,000 | 0.38% |
| EAM Investors, LLC | 52,833 | $574,000 | 0.13% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 31,404 | $341,000 | 0.05% |
| Nikko Asset Management Americas, Inc. | 280,548 | $3,050,000 | 0.05% |
| MGO ONE SEVEN LLC | 14,900 | $161,000 | 0.04% |
| Qube Research & Technologies Ltd | 67,702 | $736,000 | 0.02% |